scholarly article | Q13442814 |
P2093 | author name string | Kai Wang | |
Lin Li | |||
Yingying Sun | |||
Guangfeng Zhang | |||
Baozhong Shen | |||
Xilin Sun | |||
Kezheng Wang | |||
P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
Active drug targeting with immunoconjugates to choroidal neovascularization | Q30659904 | ||
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. | Q33963908 | ||
Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer | Q34381481 | ||
Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression | Q35089199 | ||
Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization | Q36423573 | ||
Ophthalmic manifestation of skull base metastasis from breast cancer | Q36576958 | ||
Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions | Q36813062 | ||
Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence | Q36996613 | ||
Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer | Q37641757 | ||
Correlation between Ki67 and breast cancer prognosis | Q38077896 | ||
YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis | Q38961222 | ||
Exposure to parabens at the concentration of maximal proliferative response increases migratory and invasive activity of human breast cancer cells in vitro. | Q39013327 | ||
Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells | Q39132159 | ||
Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention | Q42409009 | ||
Assessment of CD105, α-SMA and VEGF expression in gastric carcinomas | Q44019708 | ||
Tumor-to-breast volume ratio as measured on MRI: a possible predictor of breast-conserving surgery versus mastectomy | Q45796977 | ||
Distinguishing breast skin lesions from superficial breast parenchymal lesions: diagnostic criteria, imaging characteristics, and pitfalls. | Q53191419 | ||
Detection of breast malignancy: diagnostic MR protocol for improved specificity. | Q53620396 | ||
Magnetic Resonance Imaging of the Breast Prior to Biopsy | Q57736553 | ||
A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues | Q70755356 | ||
Update of breast MR imaging architectural interpretation model | Q73807734 | ||
[The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers] | Q76378844 | ||
Meta-analysis of MR imaging in the diagnosis of breast lesions | Q79909271 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
magnetic resonance imaging | Q161238 | ||
P304 | page(s) | 376-382 | |
P577 | publication date | 2015-02-01 | |
P1433 | published in | Medical Science Monitor | Q15756323 |
P1476 | title | Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer | |
P478 | volume | 21 |
Q88734990 | Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration? |
Q93198496 | Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ |
Q95276807 | Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging |
Q55266586 | Apparent Diffusion Coefficient to Subdivide Breast Imaging Reporting and Data System Magnetic Resonance Imaging (BI-RADS-MRI) Category 4 Lesions. |
Q38866273 | Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI: Preliminary Observation. |
Q55317843 | Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 2: ADCmin. |
Q50756326 | Breast MRI radiogenomics: Current status and research implications. |
Q55279713 | Can Imaging Parameters Provide Information Regarding Histopathology in Head and Neck Squamous Cell Carcinoma? A Meta-Analysis. |
Q90727310 | Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions |
Q55286708 | Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis. |
Q53066147 | Characterization of indeterminate soft tissue masses referred for biopsy: What is the added value of contrast imaging at 3.0 tesla? |
Q92990885 | Circulating miRNAs in Untreated Breast Cancer: An Exploratory Multimodality Morpho-Functional Study |
Q47788266 | Clinical role of breast MRI now and going forward. |
Q39246340 | Contrast agents in dynamic contrast-enhanced magnetic resonance imaging |
Q89566797 | Correlation between the dynamic contrast-enhanced MRI features and prognostic factors in breast cancer: A retrospective case-control study |
Q37442942 | Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma |
Q47270135 | DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers. |
Q48322318 | Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging |
Q53060422 | Discrimination of metastatic from non-metastatic mesorectal lymph nodes in rectal cancer using quantitative dynamic contrast-enhanced magnetic resonance imaging. |
Q36236333 | Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis |
Q39676450 | Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status |
Q91674874 | Evaluating the scope of intramedullary invasion of malignant bone tumor by DCE-MRI quantitative parameters in animal study |
Q33599166 | Evaluation of optimized magnetic resonance perfusion imaging scanning time window after contrast agent injection for differentiating benign and malignant breast lesions |
Q47676027 | Feasibility of free-breathing dynamic contrast-enhanced MRI of gastric cancer using a golden-angle radial stack-of-stars VIBE sequence: comparison with the conventional contrast-enhanced breath-hold 3D VIBE sequence |
Q59812683 | Feasibility study of dual parametric 2D histogram analysis of breast lesions with dynamic contrast-enhanced and diffusion-weighted MRI |
Q55000387 | Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma. |
Q36902060 | How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis? |
Q88721778 | Hyperbaric oxygen can induce angiogenesis and recover erectile function |
Q91796697 | In-cell determination of Lactate Dehydrogenase Activity in a Luminal Breast Cancer Model ⁻ ex vivo Investigation of Excised Xenograft Tumor Slices Using dDNP Hyperpolarized [1-13C]pyruvate |
Q64229780 | Magnetic Resonance Angiography Shows Increased Arterial Blood Supply Associated with Murine Mammary Cancer |
Q36353794 | Multiparametric MR Imaging of Breast Cancer |
Q39390258 | Multiparametric MRI of the breast: A review |
Q99550178 | Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer |
Q53034336 | Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer. |
Q47764942 | Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density |
Q37095230 | Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma |
Q38996663 | The potential of multiparametric MRI of the breast |
Q57067892 | Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density |
Q92267228 | Whole-lesion ADC histogram analysis is not able to reflect microvessel density in HNSCC |
Search more.